Skip to main content

Table 2 Pregnancy outcomes of total patients according to AMH level

From: Association of antimüllerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer

Outcomes

Serum AMH, ng/mL

P-value

 ≤ 2.25 (n = 746)

2.25–5.71 (n = 1486)

 > 5.71 (n = 741)

Implantation rate

0.42 ± 0.41a,b

0.50 ± 0.43

0.53 ± 0.42

 < 0.0011

Clinical pregnancy rate

58.8% (439/746)a,b

64.7% (961/1486)b

69.9% (518/741)

 < 0.0012

Miscarriage rate

18.0% (79/439)c

12.9% (124/961)

12.7% (66/518)

0.0242

  Early miscarriage rate

13.4% (59/439)d

9.7% (93/961)

8.3% (43/518)

0.0252

  Late miscarriage rate

4.6% (20/439)

3.2% (31/961)

4.4% (23/518)

0.3532

Live birth rate

47.6% (354/743)a,b

55.2% (814/1474)

59.5% (436/733)

 < 0.0012

No. of live babies delivered

   

0.0072

  1

75.7% (268/354)e

69.8% (568/814)

65.4% (285/436)

 

   ≥ 2

24.3% (86/354)

30.2% (246/814)

34.6% (151/436)

 
  1. Note: Continuous variables: 1Kruskal-Wallis test followed by a post-hoc pairwise comparison. Categorical variables: 2Chi-square test followed by post-hoc Bonferroni correction
  2. aP < 0.001, statistically significant differences from average-AMH group
  3. bP < 0.001, statistically significant differences from high-AMH group
  4. cP < 0.05, statistically significant differences from average-AMH group
  5. dP < 0.05, statistically significant differences from high-AMH group
  6. eP < 0.01, statistically significant differences from high-AMH group